nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—CYP3A4—Temozolomide—malignant glioma	0.295	1	CbGbCtD
Atazanavir—Dysplasia—Carmustine—malignant glioma	0.0765	0.139	CcSEcCtD
Atazanavir—Opportunistic infection—Temozolomide—malignant glioma	0.0153	0.0277	CcSEcCtD
Atazanavir—Lopinavir—CYP2B6—malignant glioma	0.0121	0.543	CrCbGaD
Atazanavir—Ritonavir—CYP2B6—malignant glioma	0.0101	0.457	CrCbGaD
Atazanavir—Myasthenia—Carmustine—malignant glioma	0.0101	0.0184	CcSEcCtD
Atazanavir—Burning sensation—Carmustine—malignant glioma	0.00917	0.0166	CcSEcCtD
Atazanavir—Myopathy—Temozolomide—malignant glioma	0.00878	0.0159	CcSEcCtD
Atazanavir—Cholestasis—Temozolomide—malignant glioma	0.00811	0.0147	CcSEcCtD
Atazanavir—Liver injury—Temozolomide—malignant glioma	0.00732	0.0133	CcSEcCtD
Atazanavir—Amenorrhoea—Temozolomide—malignant glioma	0.00701	0.0127	CcSEcCtD
Atazanavir—Drug interaction—Carmustine—malignant glioma	0.00687	0.0124	CcSEcCtD
Atazanavir—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00677	0.0123	CcSEcCtD
Atazanavir—Gait disturbance—Carmustine—malignant glioma	0.00653	0.0118	CcSEcCtD
Atazanavir—Gait disturbance—Temozolomide—malignant glioma	0.00631	0.0114	CcSEcCtD
Atazanavir—Gynaecomastia—Carmustine—malignant glioma	0.0057	0.0103	CcSEcCtD
Atazanavir—Diabetes mellitus—Carmustine—malignant glioma	0.00532	0.00963	CcSEcCtD
Atazanavir—Gastroenteritis—Temozolomide—malignant glioma	0.00504	0.00914	CcSEcCtD
Atazanavir—Vascular purpura—Temozolomide—malignant glioma	0.005	0.00905	CcSEcCtD
Atazanavir—Amnesia—Carmustine—malignant glioma	0.00492	0.00892	CcSEcCtD
Atazanavir—Nasal congestion—Temozolomide—malignant glioma	0.00491	0.00889	CcSEcCtD
Atazanavir—Amnesia—Temozolomide—malignant glioma	0.00476	0.00862	CcSEcCtD
Atazanavir—Purpura—Temozolomide—malignant glioma	0.00464	0.0084	CcSEcCtD
Atazanavir—Affect lability—Temozolomide—malignant glioma	0.0044	0.00797	CcSEcCtD
Atazanavir—Mood swings—Temozolomide—malignant glioma	0.00424	0.00767	CcSEcCtD
Atazanavir—Dehydration—Temozolomide—malignant glioma	0.00416	0.00753	CcSEcCtD
Atazanavir—Dry skin—Temozolomide—malignant glioma	0.0041	0.00742	CcSEcCtD
Atazanavir—Muscular weakness—Carmustine—malignant glioma	0.00408	0.00739	CcSEcCtD
Atazanavir—Breast disorder—Temozolomide—malignant glioma	0.00404	0.00732	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00403	0.00729	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00394	0.00714	CcSEcCtD
Atazanavir—Muscular weakness—Temozolomide—malignant glioma	0.00394	0.00714	CcSEcCtD
Atazanavir—Abdominal distension—Temozolomide—malignant glioma	0.00389	0.00705	CcSEcCtD
Atazanavir—Neutropenia—Carmustine—malignant glioma	0.00374	0.00677	CcSEcCtD
Atazanavir—Neutropenia—Temozolomide—malignant glioma	0.00361	0.00654	CcSEcCtD
Atazanavir—Hyperglycaemia—Carmustine—malignant glioma	0.00361	0.00653	CcSEcCtD
Atazanavir—Pollakiuria—Temozolomide—malignant glioma	0.00357	0.00646	CcSEcCtD
Atazanavir—Erectile dysfunction—Temozolomide—malignant glioma	0.00356	0.00645	CcSEcCtD
Atazanavir—Depression—Carmustine—malignant glioma	0.00355	0.00644	CcSEcCtD
Atazanavir—Photosensitivity reaction—Temozolomide—malignant glioma	0.00353	0.00639	CcSEcCtD
Atazanavir—Weight increased—Temozolomide—malignant glioma	0.00352	0.00637	CcSEcCtD
Atazanavir—Renal failure—Carmustine—malignant glioma	0.0035	0.00635	CcSEcCtD
Atazanavir—Weight decreased—Temozolomide—malignant glioma	0.0035	0.00633	CcSEcCtD
Atazanavir—Neuropathy peripheral—Carmustine—malignant glioma	0.00349	0.00633	CcSEcCtD
Atazanavir—Hyperglycaemia—Temozolomide—malignant glioma	0.00349	0.00631	CcSEcCtD
Atazanavir—Stomatitis—Carmustine—malignant glioma	0.00347	0.00629	CcSEcCtD
Atazanavir—Urinary tract infection—Carmustine—malignant glioma	0.00347	0.00628	CcSEcCtD
Atazanavir—Depression—Temozolomide—malignant glioma	0.00344	0.00622	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00342	0.00619	CcSEcCtD
Atazanavir—Neuropathy peripheral—Temozolomide—malignant glioma	0.00338	0.00612	CcSEcCtD
Atazanavir—Stomatitis—Temozolomide—malignant glioma	0.00336	0.00608	CcSEcCtD
Atazanavir—Urinary tract infection—Temozolomide—malignant glioma	0.00335	0.00607	CcSEcCtD
Atazanavir—Hepatobiliary disease—Temozolomide—malignant glioma	0.00326	0.0059	CcSEcCtD
Atazanavir—Hypoaesthesia—Carmustine—malignant glioma	0.00318	0.00577	CcSEcCtD
Atazanavir—Hallucination—Carmustine—malignant glioma	0.00318	0.00577	CcSEcCtD
Atazanavir—Oedema peripheral—Carmustine—malignant glioma	0.00315	0.00571	CcSEcCtD
Atazanavir—Connective tissue disorder—Carmustine—malignant glioma	0.00314	0.0057	CcSEcCtD
Atazanavir—Hepatitis—Temozolomide—malignant glioma	0.00309	0.0056	CcSEcCtD
Atazanavir—Hypoaesthesia—Temozolomide—malignant glioma	0.00308	0.00557	CcSEcCtD
Atazanavir—Hallucination—Temozolomide—malignant glioma	0.00308	0.00557	CcSEcCtD
Atazanavir—Urinary tract disorder—Temozolomide—malignant glioma	0.00305	0.00553	CcSEcCtD
Atazanavir—Oedema peripheral—Temozolomide—malignant glioma	0.00305	0.00552	CcSEcCtD
Atazanavir—Connective tissue disorder—Temozolomide—malignant glioma	0.00304	0.0055	CcSEcCtD
Atazanavir—Urethral disorder—Temozolomide—malignant glioma	0.00303	0.00549	CcSEcCtD
Atazanavir—Eye disorder—Carmustine—malignant glioma	0.00299	0.00542	CcSEcCtD
Atazanavir—Erythema multiforme—Temozolomide—malignant glioma	0.00292	0.0053	CcSEcCtD
Atazanavir—Eye disorder—Temozolomide—malignant glioma	0.00289	0.00523	CcSEcCtD
Atazanavir—Tinnitus—Temozolomide—malignant glioma	0.00288	0.00522	CcSEcCtD
Atazanavir—Cardiac disorder—Temozolomide—malignant glioma	0.00287	0.0052	CcSEcCtD
Atazanavir—Alopecia—Carmustine—malignant glioma	0.00283	0.00512	CcSEcCtD
Atazanavir—Angiopathy—Temozolomide—malignant glioma	0.00281	0.00508	CcSEcCtD
Atazanavir—Mental disorder—Carmustine—malignant glioma	0.0028	0.00508	CcSEcCtD
Atazanavir—Immune system disorder—Temozolomide—malignant glioma	0.00279	0.00506	CcSEcCtD
Atazanavir—Mediastinal disorder—Temozolomide—malignant glioma	0.00279	0.00505	CcSEcCtD
Atazanavir—Malnutrition—Carmustine—malignant glioma	0.00279	0.00505	CcSEcCtD
Atazanavir—Alopecia—Temozolomide—malignant glioma	0.00273	0.00495	CcSEcCtD
Atazanavir—Mental disorder—Temozolomide—malignant glioma	0.00271	0.00491	CcSEcCtD
Atazanavir—Back pain—Carmustine—malignant glioma	0.00269	0.00488	CcSEcCtD
Atazanavir—Malnutrition—Temozolomide—malignant glioma	0.00269	0.00488	CcSEcCtD
Atazanavir—Dysgeusia—Temozolomide—malignant glioma	0.00264	0.00478	CcSEcCtD
Atazanavir—Back pain—Temozolomide—malignant glioma	0.0026	0.00472	CcSEcCtD
Atazanavir—Agitation—Carmustine—malignant glioma	0.00256	0.00464	CcSEcCtD
Atazanavir—Ill-defined disorder—Temozolomide—malignant glioma	0.0025	0.00452	CcSEcCtD
Atazanavir—Agitation—Temozolomide—malignant glioma	0.00247	0.00448	CcSEcCtD
Atazanavir—Angioedema—Temozolomide—malignant glioma	0.00246	0.00446	CcSEcCtD
Atazanavir—Malaise—Temozolomide—malignant glioma	0.00243	0.0044	CcSEcCtD
Atazanavir—Convulsion—Carmustine—malignant glioma	0.00241	0.00437	CcSEcCtD
Atazanavir—Hypertension—Carmustine—malignant glioma	0.00241	0.00436	CcSEcCtD
Atazanavir—Palpitations—Temozolomide—malignant glioma	0.00238	0.00431	CcSEcCtD
Atazanavir—Myalgia—Carmustine—malignant glioma	0.00237	0.0043	CcSEcCtD
Atazanavir—Chest pain—Carmustine—malignant glioma	0.00237	0.0043	CcSEcCtD
Atazanavir—Anxiety—Carmustine—malignant glioma	0.00236	0.00428	CcSEcCtD
Atazanavir—Cough—Temozolomide—malignant glioma	0.00235	0.00426	CcSEcCtD
Atazanavir—Convulsion—Temozolomide—malignant glioma	0.00233	0.00422	CcSEcCtD
Atazanavir—Hypertension—Temozolomide—malignant glioma	0.00232	0.00421	CcSEcCtD
Atazanavir—Confusional state—Carmustine—malignant glioma	0.00229	0.00415	CcSEcCtD
Atazanavir—Arthralgia—Temozolomide—malignant glioma	0.00229	0.00415	CcSEcCtD
Atazanavir—Myalgia—Temozolomide—malignant glioma	0.00229	0.00415	CcSEcCtD
Atazanavir—Anxiety—Temozolomide—malignant glioma	0.00228	0.00414	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00228	0.00412	CcSEcCtD
Atazanavir—Oedema—Carmustine—malignant glioma	0.00227	0.00412	CcSEcCtD
Atazanavir—Discomfort—Temozolomide—malignant glioma	0.00226	0.0041	CcSEcCtD
Atazanavir—Infection—Carmustine—malignant glioma	0.00226	0.00409	CcSEcCtD
Atazanavir—Dry mouth—Temozolomide—malignant glioma	0.00224	0.00406	CcSEcCtD
Atazanavir—Confusional state—Temozolomide—malignant glioma	0.00222	0.00401	CcSEcCtD
Atazanavir—Oedema—Temozolomide—malignant glioma	0.0022	0.00398	CcSEcCtD
Atazanavir—Infection—Temozolomide—malignant glioma	0.00218	0.00395	CcSEcCtD
Atazanavir—Anorexia—Carmustine—malignant glioma	0.00217	0.00393	CcSEcCtD
Atazanavir—Nervous system disorder—Temozolomide—malignant glioma	0.00215	0.0039	CcSEcCtD
Atazanavir—Skin disorder—Temozolomide—malignant glioma	0.00213	0.00387	CcSEcCtD
Atazanavir—Hyperhidrosis—Temozolomide—malignant glioma	0.00212	0.00385	CcSEcCtD
Atazanavir—Anorexia—Temozolomide—malignant glioma	0.00209	0.00379	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00207	0.00375	CcSEcCtD
Atazanavir—Insomnia—Carmustine—malignant glioma	0.00206	0.00372	CcSEcCtD
Atazanavir—Dyspnoea—Carmustine—malignant glioma	0.00203	0.00367	CcSEcCtD
Atazanavir—Somnolence—Carmustine—malignant glioma	0.00202	0.00366	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.002	0.00363	CcSEcCtD
Atazanavir—Insomnia—Temozolomide—malignant glioma	0.00199	0.0036	CcSEcCtD
Atazanavir—Decreased appetite—Carmustine—malignant glioma	0.00198	0.00358	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Carmustine—malignant glioma	0.00196	0.00356	CcSEcCtD
Atazanavir—Dyspnoea—Temozolomide—malignant glioma	0.00196	0.00355	CcSEcCtD
Atazanavir—Somnolence—Temozolomide—malignant glioma	0.00195	0.00354	CcSEcCtD
Atazanavir—Pain—Carmustine—malignant glioma	0.00194	0.00352	CcSEcCtD
Atazanavir—Constipation—Carmustine—malignant glioma	0.00194	0.00352	CcSEcCtD
Atazanavir—Dyspepsia—Temozolomide—malignant glioma	0.00193	0.0035	CcSEcCtD
Atazanavir—Decreased appetite—Temozolomide—malignant glioma	0.00191	0.00346	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0019	0.00344	CcSEcCtD
Atazanavir—Fatigue—Temozolomide—malignant glioma	0.00189	0.00343	CcSEcCtD
Atazanavir—Pain—Temozolomide—malignant glioma	0.00188	0.0034	CcSEcCtD
Atazanavir—Constipation—Temozolomide—malignant glioma	0.00188	0.0034	CcSEcCtD
Atazanavir—Feeling abnormal—Carmustine—malignant glioma	0.00187	0.00339	CcSEcCtD
Atazanavir—Gastrointestinal pain—Carmustine—malignant glioma	0.00186	0.00337	CcSEcCtD
Atazanavir—Feeling abnormal—Temozolomide—malignant glioma	0.00181	0.00328	CcSEcCtD
Atazanavir—Abdominal pain—Carmustine—malignant glioma	0.0018	0.00326	CcSEcCtD
Atazanavir—Body temperature increased—Carmustine—malignant glioma	0.0018	0.00326	CcSEcCtD
Atazanavir—Gastrointestinal pain—Temozolomide—malignant glioma	0.0018	0.00325	CcSEcCtD
Atazanavir—Urticaria—Temozolomide—malignant glioma	0.00175	0.00316	CcSEcCtD
Atazanavir—Abdominal pain—Temozolomide—malignant glioma	0.00174	0.00315	CcSEcCtD
Atazanavir—Body temperature increased—Temozolomide—malignant glioma	0.00174	0.00315	CcSEcCtD
Atazanavir—Hypersensitivity—Carmustine—malignant glioma	0.00168	0.00303	CcSEcCtD
Atazanavir—Asthenia—Carmustine—malignant glioma	0.00163	0.00295	CcSEcCtD
Atazanavir—Hypersensitivity—Temozolomide—malignant glioma	0.00162	0.00293	CcSEcCtD
Atazanavir—Asthenia—Temozolomide—malignant glioma	0.00158	0.00286	CcSEcCtD
Atazanavir—Diarrhoea—Carmustine—malignant glioma	0.00156	0.00282	CcSEcCtD
Atazanavir—Pruritus—Temozolomide—malignant glioma	0.00155	0.00282	CcSEcCtD
Atazanavir—Dizziness—Carmustine—malignant glioma	0.0015	0.00272	CcSEcCtD
Atazanavir—Diarrhoea—Temozolomide—malignant glioma	0.0015	0.00272	CcSEcCtD
Atazanavir—Dizziness—Temozolomide—malignant glioma	0.00145	0.00263	CcSEcCtD
Atazanavir—Vomiting—Carmustine—malignant glioma	0.00145	0.00262	CcSEcCtD
Atazanavir—Rash—Carmustine—malignant glioma	0.00143	0.0026	CcSEcCtD
Atazanavir—Dermatitis—Carmustine—malignant glioma	0.00143	0.00259	CcSEcCtD
Atazanavir—Headache—Carmustine—malignant glioma	0.00142	0.00258	CcSEcCtD
Atazanavir—Vomiting—Temozolomide—malignant glioma	0.0014	0.00253	CcSEcCtD
Atazanavir—Rash—Temozolomide—malignant glioma	0.00139	0.00251	CcSEcCtD
Atazanavir—Dermatitis—Temozolomide—malignant glioma	0.00138	0.00251	CcSEcCtD
Atazanavir—Headache—Temozolomide—malignant glioma	0.00138	0.00249	CcSEcCtD
Atazanavir—Nausea—Carmustine—malignant glioma	0.00135	0.00245	CcSEcCtD
Atazanavir—Nausea—Temozolomide—malignant glioma	0.00131	0.00236	CcSEcCtD
Atazanavir—ABCC1—Metabolism—COX8A—malignant glioma	0.000256	0.00196	CbGpPWpGaD
Atazanavir—ABCC1—Disease—BCAN—malignant glioma	0.000245	0.00187	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000238	0.00182	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—IDH2—malignant glioma	0.000234	0.00179	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000231	0.00177	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000229	0.00175	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000228	0.00174	CbGpPWpGaD
Atazanavir—ABCC1—Disease—DTX1—malignant glioma	0.000221	0.00169	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.00022	0.00169	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP2B6—malignant glioma	0.00022	0.00168	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ASMT—malignant glioma	0.000218	0.00167	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000218	0.00167	CbGpPWpGaD
Atazanavir—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	0.000215	0.00165	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000213	0.00163	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—RTEL1—malignant glioma	0.000212	0.00163	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—IFNG—malignant glioma	0.000211	0.00162	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000208	0.00159	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—BCAN—malignant glioma	0.000205	0.00157	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	0.000203	0.00155	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000203	0.00155	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—IDH1—malignant glioma	0.000201	0.00154	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.0002	0.00153	CbGpPWpGaD
Atazanavir—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.0002	0.00153	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000198	0.00152	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—CXCL8—malignant glioma	0.000197	0.00151	CbGpPWpGaD
Atazanavir—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000196	0.0015	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—SPHK1—malignant glioma	0.000194	0.00149	CbGpPWpGaD
Atazanavir—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000193	0.00148	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CYP2C18—malignant glioma	0.00019	0.00146	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00019	0.00146	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	0.000189	0.00145	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—IL1B—malignant glioma	0.000189	0.00144	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—CASP3—malignant glioma	0.000188	0.00144	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—IL2—malignant glioma	0.000188	0.00144	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	0.000187	0.00143	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000187	0.00143	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	0.000184	0.00141	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00018	0.00138	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000175	0.00134	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HEY2—malignant glioma	0.000174	0.00133	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	0.00017	0.0013	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IDH1—malignant glioma	0.00017	0.0013	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—IDH2—malignant glioma	0.000165	0.00126	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000164	0.00125	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HEY1—malignant glioma	0.000161	0.00123	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—VEGFA—malignant glioma	0.00016	0.00122	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000158	0.00121	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HIST1H3B—malignant glioma	0.000156	0.0012	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000156	0.00119	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP2B6—malignant glioma	0.000155	0.00119	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GSTT1—malignant glioma	0.000154	0.00118	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	0.000152	0.00116	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTGS1—malignant glioma	0.000144	0.00111	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000144	0.0011	CbGpPWpGaD
Atazanavir—ABCC1—Disease—JAG2—malignant glioma	0.000143	0.00109	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—IDH1—malignant glioma	0.000142	0.00109	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000142	0.00109	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—SPHK1—malignant glioma	0.000137	0.00105	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000137	0.00105	CbGpPWpGaD
Atazanavir—ABCB1—Allograft Rejection—TNF—malignant glioma	0.000137	0.00105	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	0.000136	0.00104	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP2C18—malignant glioma	0.000135	0.00103	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—BCHE—malignant glioma	0.000134	0.00103	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—SLC5A5—malignant glioma	0.000133	0.00101	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	0.000132	0.00101	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000131	0.001	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	0.00013	0.000997	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000129	0.000991	CbGpPWpGaD
Atazanavir—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000128	0.000977	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000127	0.000972	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000125	0.00096	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000124	0.000951	CbGpPWpGaD
Atazanavir—SLCO1B3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000122	0.000935	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—COX8A—malignant glioma	0.000122	0.000934	CbGpPWpGaD
Atazanavir—ABCC1—Disease—H3F3A—malignant glioma	0.000121	0.000924	CbGpPWpGaD
Atazanavir—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	0.000118	0.000901	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000116	0.000886	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—COX8A—malignant glioma	0.000114	0.000872	CbGpPWpGaD
Atazanavir—ABCC1—Disease—JAG1—malignant glioma	0.000114	0.000871	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000112	0.000855	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FBXW7—malignant glioma	0.000111	0.000853	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	0.000111	0.000849	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTT1—malignant glioma	0.000109	0.000834	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000108	0.000829	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—GSTP1—malignant glioma	0.000107	0.000818	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	0.000105	0.000806	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CAT—malignant glioma	0.000104	0.000796	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	0.000104	0.000795	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ASMT—malignant glioma	0.000104	0.000794	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000104	0.000794	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	0.000103	0.000792	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	0.000102	0.000783	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTGS1—malignant glioma	0.000102	0.000781	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000102	0.00078	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000102	0.000779	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	0.0001	0.000766	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—NCOR1—malignant glioma	9.81e-05	0.000751	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—BCAN—malignant glioma	9.75e-05	0.000746	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ASMT—malignant glioma	9.69e-05	0.000742	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	9.52e-05	0.000729	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—BCHE—malignant glioma	9.49e-05	0.000726	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	9.47e-05	0.000725	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—SLC5A5—malignant glioma	9.37e-05	0.000718	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	9.29e-05	0.000711	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—BCAN—malignant glioma	9.11e-05	0.000697	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.06e-05	0.000694	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.86e-05	0.000679	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.78e-05	0.000672	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN2B—malignant glioma	8.73e-05	0.000669	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	8.73e-05	0.000668	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—RAF1—malignant glioma	8.63e-05	0.000661	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HES1—malignant glioma	8.33e-05	0.000638	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NCOR1—malignant glioma	8.28e-05	0.000634	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CAV1—malignant glioma	8e-05	0.000612	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PDGFRA—malignant glioma	7.93e-05	0.000607	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	7.88e-05	0.000603	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—IDH2—malignant glioma	7.86e-05	0.000602	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.66e-05	0.000586	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.64e-05	0.000585	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTP1—malignant glioma	7.55e-05	0.000578	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—COX8A—malignant glioma	7.51e-05	0.000575	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2B6—malignant glioma	7.39e-05	0.000566	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CAT—malignant glioma	7.35e-05	0.000562	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—IDH2—malignant glioma	7.34e-05	0.000562	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TERT—malignant glioma	7.3e-05	0.000559	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HLA-A—malignant glioma	7.3e-05	0.000559	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CG—malignant glioma	7.29e-05	0.000558	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	7.25e-05	0.000555	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PDGFB—malignant glioma	7.13e-05	0.000546	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	7.09e-05	0.000543	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FGFR1—malignant glioma	7.09e-05	0.000543	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PPARG—malignant glioma	7.03e-05	0.000538	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HIF1A—malignant glioma	6.98e-05	0.000535	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—NCOR1—malignant glioma	6.94e-05	0.000531	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	6.92e-05	0.00053	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2B6—malignant glioma	6.9e-05	0.000528	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—IDH1—malignant glioma	6.76e-05	0.000517	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	6.75e-05	0.000517	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CAV1—malignant glioma	6.75e-05	0.000517	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	6.7e-05	0.000513	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SPHK1—malignant glioma	6.54e-05	0.000501	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2C18—malignant glioma	6.41e-05	0.000491	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CD—malignant glioma	6.41e-05	0.00049	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ASMT—malignant glioma	6.39e-05	0.000489	CbGpPWpGaD
Atazanavir—ABCC1—Disease—BAD—malignant glioma	6.35e-05	0.000486	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—IDH1—malignant glioma	6.31e-05	0.000483	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NOTCH1—malignant glioma	6.29e-05	0.000482	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CD80—malignant glioma	6.16e-05	0.000472	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	6.16e-05	0.000471	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APC—malignant glioma	6.15e-05	0.000471	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SPHK1—malignant glioma	6.11e-05	0.000468	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EGF—malignant glioma	6.08e-05	0.000465	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTPN11—malignant glioma	6.04e-05	0.000463	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—BCAN—malignant glioma	6.01e-05	0.00046	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2C18—malignant glioma	5.99e-05	0.000458	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	5.95e-05	0.000456	CbGpPWpGaD
Atazanavir—ABCC1—Disease—BRAF—malignant glioma	5.78e-05	0.000443	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CAV1—malignant glioma	5.66e-05	0.000433	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.64e-05	0.000432	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT2—malignant glioma	5.63e-05	0.000431	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CB—malignant glioma	5.58e-05	0.000427	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTGS2—malignant glioma	5.53e-05	0.000424	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CD—malignant glioma	5.41e-05	0.000414	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.4e-05	0.000414	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTT1—malignant glioma	5.18e-05	0.000397	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FGF2—malignant glioma	5.18e-05	0.000396	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CG—malignant glioma	5.15e-05	0.000394	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.14e-05	0.000394	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	5.03e-05	0.000385	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PPARG—malignant glioma	4.97e-05	0.000381	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.96e-05	0.00038	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS1—malignant glioma	4.86e-05	0.000372	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MDM2—malignant glioma	4.84e-05	0.000371	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—IDH2—malignant glioma	4.84e-05	0.000371	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTT1—malignant glioma	4.84e-05	0.000371	CbGpPWpGaD
Atazanavir—ABCC1—Disease—RAF1—malignant glioma	4.83e-05	0.00037	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTEN—malignant glioma	4.82e-05	0.000369	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ERBB2—malignant glioma	4.78e-05	0.000366	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CB—malignant glioma	4.71e-05	0.000361	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTGS2—malignant glioma	4.67e-05	0.000358	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.55e-05	0.000349	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS1—malignant glioma	4.54e-05	0.000347	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CD—malignant glioma	4.53e-05	0.000347	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.52e-05	0.000346	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—BCHE—malignant glioma	4.51e-05	0.000346	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SLC5A5—malignant glioma	4.46e-05	0.000341	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—BCHE—malignant glioma	4.22e-05	0.000323	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SLC5A5—malignant glioma	4.17e-05	0.000319	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—IDH1—malignant glioma	4.16e-05	0.000319	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	4.11e-05	0.000314	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTEN—malignant glioma	4.07e-05	0.000312	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SPHK1—malignant glioma	4.03e-05	0.000308	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CB—malignant glioma	3.95e-05	0.000302	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.95e-05	0.000302	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.94e-05	0.000302	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTGS2—malignant glioma	3.91e-05	0.000299	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.9e-05	0.000299	CbGpPWpGaD
Atazanavir—ABCC1—Disease—STAT3—malignant glioma	3.64e-05	0.000279	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTP1—malignant glioma	3.59e-05	0.000275	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CAT—malignant glioma	3.49e-05	0.000268	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTEN—malignant glioma	3.41e-05	0.000261	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.4e-05	0.000261	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CA—malignant glioma	3.4e-05	0.000261	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MYC—malignant glioma	3.38e-05	0.000259	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTP1—malignant glioma	3.36e-05	0.000257	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EGFR—malignant glioma	3.31e-05	0.000253	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NCOR1—malignant glioma	3.3e-05	0.000253	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CAT—malignant glioma	3.26e-05	0.00025	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTT1—malignant glioma	3.19e-05	0.000244	CbGpPWpGaD
Atazanavir—ABCC1—Disease—KRAS—malignant glioma	3.13e-05	0.000239	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NCOR1—malignant glioma	3.08e-05	0.000236	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS1—malignant glioma	2.99e-05	0.000229	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CA—malignant glioma	2.87e-05	0.00022	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—BCHE—malignant glioma	2.78e-05	0.000213	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AKT1—malignant glioma	2.78e-05	0.000213	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.75e-05	0.00021	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CAV1—malignant glioma	2.69e-05	0.000206	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CAV1—malignant glioma	2.51e-05	0.000192	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CG—malignant glioma	2.45e-05	0.000188	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CA—malignant glioma	2.41e-05	0.000184	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.4e-05	0.000184	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPARG—malignant glioma	2.37e-05	0.000181	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT1—malignant glioma	2.35e-05	0.00018	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CG—malignant glioma	2.29e-05	0.000175	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTP1—malignant glioma	2.21e-05	0.000169	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPARG—malignant glioma	2.21e-05	0.000169	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CD—malignant glioma	2.15e-05	0.000165	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CAT—malignant glioma	2.15e-05	0.000165	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NCOR1—malignant glioma	2.03e-05	0.000156	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CD—malignant glioma	2.01e-05	0.000154	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AKT1—malignant glioma	1.97e-05	0.00015	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CB—malignant glioma	1.88e-05	0.000144	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS2—malignant glioma	1.86e-05	0.000142	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CB—malignant glioma	1.75e-05	0.000134	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS2—malignant glioma	1.74e-05	0.000133	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CAV1—malignant glioma	1.66e-05	0.000127	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTEN—malignant glioma	1.62e-05	0.000124	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTEN—malignant glioma	1.52e-05	0.000116	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.51e-05	0.000116	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPARG—malignant glioma	1.46e-05	0.000112	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.33e-05	0.000102	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.16e-05	8.86e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS2—malignant glioma	1.15e-05	8.78e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CA—malignant glioma	1.14e-05	8.76e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.07e-05	8.19e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTEN—malignant glioma	1e-05	7.65e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKT1—malignant glioma	9.35e-06	7.16e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKT1—malignant glioma	8.74e-06	6.69e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CA—malignant glioma	7.05e-06	5.4e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKT1—malignant glioma	5.76e-06	4.41e-05	CbGpPWpGaD
